Up-regulation of Sox2 Gene in Cattle Fibroblast Cells using TALE-TF

Document Type : Genetics & breeding

Authors

• Yasaman Shamshirgaran ¹
• Mojtaba Tahmoorespur ²
• Hesam Dehghani ³
• Mohammad Reza Nassiry ⁴

¹ Department of Animal Science, Faculty of Agriculture, University of Birjand

² Department of Animal Sciences, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, Iran

³ Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran

⁴ Department of Animal Sciences, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, Iran.

10.22067/ijasr.v7i1.23821

Abstract

Introduction Cellular processes can be controlled by induction or repression of gene expression by introduction of exogenous genes and RNA interference (RNAi), respectively. However, the use of recently-developed specific DNA-binding transcription factors offer various advantages when compared to the exogenous gene introduction and RNAi for up or down regulation of gene expression. Sox2 gene encodes one of the most important transcription factors involved in the pluripotency state of mammalian cells. In this study the potential use of Transcription Activator-Like Effector-Transcription Factors (TALE-TFs) for endogenous up-regulation of Sox2 gene in cattle fibroblast cells were examined.
Materials and Methods At first, a 320 base pair region of bovine Sox2 gene were sequenced and showed a 93.44% identity with its human orthologs. Based on the sequencing results, a previously reported Sox2-TALE-TF for human Sox2 gene was used for testing the functionality of TALE-TFs in cattle fibroblast cells. Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 50 µg/ml Penicillin and Streptomycin (Invitrogen), 1% non-essential amino acids, and 10% fetal bovine serum (FBS). For detecting the Sox2-TALE-TF activity the qRT-PCR technique and a florescent based reporter system under the control of minCMV promoter were used. For quantitative RT-PCR analysis of Sox2 mRNA levels, the cells were lysed, and total RNA isolated by using the RNeasy kit (Qiagen Inc.) and subsequently cleaned up with Turbo DNase (Ambion) according to the manufacturer’s instructions. Reverse transcription reaction was carried out using SuperScript™ III First-Strand Synthesis System for RT-PCR (Invitrogen) according to the manufacturer’s instructions. Real-time PCR analysis was performed on the 7900HT Fast Real-Time PCR system (Applied Biosystems) at standard reaction conditions using Power SYBR Green PCR Master Mix (Applied Biosystems). Briefly, after a 2 min denaturation at 95 °C, 40 cycles carried out at 95 °C for 15 s, 58 °C for 30 s and 72 °C for 30 s. Relative mRNA levels calculated with the ∆∆CT method were analyzed using SDS Version 2.4.1 software. Data presented are from an experiment with three replicates.
Results and Discussion A set of known and as yet not understood molecular mechanisms regulate the expression of genes at (post-) transcription and (post-) translation stages in eukaryotic cells. It is generally agreed that there are three main routes of influence including; 1) combinatorial fashion of regulators and DNA 2) modulation through interaction of a control factor with the transcription machinery and 3) epigenetic modifications, are responsible for regulating gene transcription in various cell types. As a result of these mechanisms, the Sox2 gene is differentially expressed in a variety of embryonic cells and adult differentiated cell types. We choose the Sox2 gene for testing TALE-TF functionality in cattle fibroblast cells due to its well-known promoter structure as well as the lack of the evidence of methylation in the immediate regulatory regions. Our data shows that the Sox2 gene already has a basal level of expression in cattle fibroblast cells, indicating that Sox2 promoter has some activity in bovine fibroblast cells. As a proof of concept, we first tested activity of Sox2-TALE-TF in HEK293 cells. Florescent microscopy results showed that minCMV promoter has high level of activity in cattle fibroblast so it would not be considered as a suitable reporter of TALE-TF functionality. Analysis of qRT-PCR results for sox2 gene in cattle fibroblast, however, showed that Sox2 expression has been increased by 3.529 fold changes in transfected cells. Several mammalian genes have reportedly been targeted with TALE-TFs, however, fold changes in abundance of targeted gene transcripts rarely is above 5 times when individual TALE-TFs were tested. A number of factors affecting TALE-TFs activity have been reported, however, due to cell type specific chromatin state, multiple cis- and trans-acting regulatory elements and epigenetic modifications are involved in the regulation of gene expression, therefore it is very difficult to predict the efficacy of a TALE-TFs without experimental validation.
Conclusion In summary current study indicated that TALE-TFs as artificial transcription factors have the ability to increase the endogenous expression of genes in cattle fibroblast cells.

Keywords

• Cattle fibroblast
• Sox2 gene
• MinCMV promoter
• TALE-TF

---

References

1- Boch, J., H. Scholze, S. Schornack, A. Landgraf, S. Hahn, S. Kay, T. Lahaye, A. Nickstadt, and U. Bonas. 2009. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326(5959):1509-1512.

2- Buganim, Y., D. A. Faddah, and R. Jaenisch. 2013. Mechanisms and models of somatic cell reprogramming. Nature Review Genetics 14(6):427-439.

3- Bultmann, S., R. Morbitzer, C. S. Schmidt, K. Thanisch, F. Spada, J. Elsaesser, T. Lahaye, and H. Leonhardt. 2012. Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers. Nucleic Acids Research 40(12):5368-5377.

4- Cermak, T., E. L. Doyle, M. Christian, L. Wang, Y. Zhang, C. Schmidt, J. A. Baller, N. V. Somia, A. J. Bogdanove, and D. F. Voytas. 2011. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Research 39(12):e82-e82.

5- Cong, L., R. Zhou, Y.-c. Kuo, M. Cunniff, and F. Zhang. 2012. Comprehensive interrogation of natural TALE DNA-binding modules and transcriptional repressor domains. Nature Communications 3:968.

6- Garg, A., J. J. Lohmueller, P. A. Silver, and T. Z. Armel. 2012. Engineering synthetic TAL effectors with orthogonal target sites. Nucleic Acids Research 40(15):7584-7595.

7- Geiβler, R., H. Scholze, S. Hahn, J. Streubel, U. Bonas, S.-E. Behrens, and J. Boch. 2011. Transcriptional activators of human genes with programmable DNA-specificity. PLoS ONE 6(5):e19509.

8- Huang, B., T. Li, L. Alonso-Gonzalez, R. Gorre, S. Keatley, A. Green, P. Turner, P. K. Kallingappa, V. Verma, and B. Oback. 2011. A virus-free poly-promoter vector induces pluripotency in quiescent bovine cells under chemically defined conditions of dual kinase inhibition. PLoS ONE 6(9):e24501.

9- Imamura, M., K. Miura, K. Iwabuchi, T. Ichisaka, M. Nakagawa, J. Lee, M. Kanatsu-Shinohara, T. Shinohara, and S. Yamanaka. 2006. Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells. BMC Developmental Biology 6(1):34.

10- Joung, J. K. and J. D. Sander. 2012. TALENs: a widely applicable technology for targeted genome editing. Nature Reviews Molecular Cell Biology 14(1):49-55.

11- Katoh, Y. and M. Katoh. 2005. Comparative genomics on SOX2 orthologs. Oncology Reports 14(3):797.

12- Lan, J., S. Hua, H. Zhang, Y. Song, J. Liu, and Y. Zhang. 2010. Methylation patterns in 5′ terminal regions of pluripotency-related genes in bovine in vitro fertilized and cloned embryos. Journal of Genetics and Genomics 37(5):297-304.

13- Leis, O., A. Eguiara, E. Lopez-Arribillaga, M. Alberdi, S. Hernandez-Garcia, K. Elorriaga, A. Pandiella, R. Rezola, and A. Martin. 2012. Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene 31(11):1354-1365.

14- Li, Y., M. Cang, A. S. Lee, K. Zhang, and D. Liu. 2011. Reprogramming of sheep fibroblasts into pluripotency under a drug-inducible expression of mouse-derived defined factors. PLoS ONE 6(1):e15947.

15- Livak, K. J. and T. D. Schmittgen. 2001. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2− ΔΔCT Method. Methods 25(4):402-408.

16- Maeder, M. L., S. J. Linder, D. Reyon, J. F. Angstman, Y. Fu, J. D. Sander, and J. K. Joung. 2013. Robust, synergistic regulation of human gene expression using TALE activators. Nature Methods (10), 243–245.

17- Maeder, M. L., S. Thibodeau-Beganny, A. Osiak, D. A. Wright, R. M. Anthony, M. Eichtinger, T. Jiang, J. E. Foley, R. J. Winfrey, and J. A. Townsend. 2008. Rapid “open-source” engineering of customized zinc-finger nucleases for highly efficient gene modification. Molecular Cell 31(2):294-301.

18- Miller, J. C., S. Tan, G. Qiao, K. A. Barlow, J. Wang, D. F. Xia, X. Meng, D. E. Paschon, E. Leung, and S. J. Hinkley. 2010. A TALE nuclease architecture for efficient genome editing. Nature Biotechnology 29(2):143-148.

19- Morbitzer, R., P. Römer, J. Boch, and T. Lahaye. 2010. Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors. Proceedings of the National Academy of Sciences 107(50):21617-21622.

20- Page, R. L., S. Ambady, W. F. Holmes, L. Vilner, D. Kole, O. Kashpur, V. Huntress, I. Vojtic, H. Whitton, and T. Dominko. 2009. Induction of stem cell gene expression in adult human fibroblasts without transgenes. Cloning and Stem Cells 11(3):417-426.

21- Perez-Pinera, P., D. G. Ousterout, J. M. Brunger, A. M. Farin, K. A. Glass, F. Guilak, G. E. Crawford, A. J. Hartemink, and C. A. Gersbach. 2013. Synergistic and tunable human gene activation by combinations of synthetic transcription factors. Nature Methods (10) 239–242.

22- Rebar, E. J., Y. Huang, R. Hickey, A. K. Nath, D. Meoli, S. Nath, B. Chen, L. Xu, Y. Liang, and A. C. Jamieson. 2002. Induction of angiogenesis in a mouse model using engineered transcription factors. Nature Medicine 8(12):1427-1432.

23- Reyon, D., S. Q. Tsai, C. Khayter, J. A. Foden, J. D. Sander, and J. K. Joung. 2012. FLASH assembly of TALENs for high-throughput genome editing. Nature Biotechnology 30(5):460-465.

24- Sander, J. D., L. Cade, C. Khayter, D. Reyon, R. T. Peterson, J. K. Joung, and J.-R. J. Yeh. 2011. Targeted gene disruption in somatic zebrafish cells using engineered TALENs. Nature Biotechnology 29(8):697.

25- Sander, J. D., P. Zaback, J. K. Joung, D. F. Voytas, and D. Dobbs. 2009. An affinity-based scoring scheme for predicting DNA-binding activities of modularly assembled zinc-finger proteins. Nucleic Acids Research 37(2):506-515.

26- Sanjana, N. E., L. Cong, Y. Zhou, M. M. Cunniff, G. Feng, and F. Zhang. 2012. A transcription activator-like effector toolbox for genome engineering. Nature Protocols 7(1):171-192.

27- Schmid-Burgk, J. L., T. Schmidt, V. Kaiser, K. Höning, and V. Hornung. 2012. A ligation-independent cloning technique for high-throughput assembly of transcription activator-like effector genes. Nature Biotechnology 31(1):76-81.

28- Snowden, A. W., L. Zhang, F. Urnov, C. Dent, Y. Jouvenot, X. Zhong, E. J. Rebar, A. C. Jamieson, H. S. Zhang, S. Tan, C. C. Case, C. O. Pabo, A. P. Wolffe, and P. D. Gregory. 2003. Repression of Vascular Endothelial Growth Factor A in Glioblastoma Cells Using Engineered Zinc Finger Transcription Factors. Cancer Research 63(24):8968-8976.

29- Takahashi, K. and S. Yamanaka. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-676.

30- Tremblay, J. P., P. Chapdelaine, Z. Coulombe, and J. Rousseau. 2012. Transcription Activator-Like Effector Proteins Induce the Expression of the Frataxin Gene. Human Gene Therapy 23(8):883-890.

31- Zhang, F., L. Cong, S. Lodato, S. Kosuri, G. M. Church, and P. Arlotta. 2011. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nature Biotechnology 29(2):149-153.